EUVIMEDEUVIMED entdecken
Leserbrief

Pediatric T‐Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission

Tatsuya Kamitori iD, Takayuki Takachi, Yoshinori Uchihara iD, Wataru Fukui, Kazuki Mitani iD, Shohei Azumi, Hideto Ogata, Koji Kawaguchi iD, Taemi Ogura, Yasuo Horikoshi, Junko Takita, Kenichiro Watanabe iD

Pediatric Blood & Cancer · 2026-08 · 73 (8)

DOI: 10.1002/1545-5017.70412 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 04.06.2026. Verfasst von Tatsuya Kamitori und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor: T-lymphoblastic lymphoma (T-LBL) harboring t(9;17) is a rare subtype of T-LBL, accounting for 4.3% of pediatric and adolescent T-LBL cases [ 1 ]. This subgroup is associated with dismal prognosis [ 1–3 ], and no effective therapeutic strategies have been established to improve outcomes. Moreover, the underlying genetic alterations have not yet been elucidated. Herein, we describe a 10-year-old boy who presented with a cough and facial edema. Computed tomography (CT) revealed a 116 × 92 mm anterior mediastinal mass with right-sided pleural dissemination and pleural effusion. CT also demonstrated bilateral supraclavicular lymphadenopathy and collapse of the superior vena cava. Cytological analysis of the pleural fluid revealed an increase in blasts, which were positive for CD3, CD2, CD4, CD5, CD7, CD8, CD11a, and TCR α / β . G-banding analysis showed that the blasts harbored t(9;17)(q34

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
  • Department of Pediatrics, Kyoto University, Kyoto, Japan.

ORCID-Profile: Tatsuya Kamitori, Yoshinori Uchihara, Kazuki Mitani, Koji Kawaguchi, Kenichiro Watanabe

Zitieren

APA

Kamitori, T., Takachi, T., Uchihara, Y., Fukui, W., Mitani, K., Azumi, S., Ogata, H., Kawaguchi, K., Ogura, T., Horikoshi, Y., Takita, J., & Watanabe, K. (2026). Pediatric T‐Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission. Pediatric Blood & Cancer, 73(8). https://doi.org/10.1002/1545-5017.70412

Vancouver

Kamitori T, Takachi T, Uchihara Y, Fukui W, Mitani K, Azumi S, et al. Pediatric T‐Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission. Pediatric Blood & Cancer. 2026;73(8). doi:10.1002/1545-5017.70412

BibTeX
@article{Kamitori2026,
  author = {Kamitori, Tatsuya and Takachi, Takayuki and Uchihara, Yoshinori and Fukui, Wataru and Mitani, Kazuki and Azumi, Shohei and Ogata, Hideto and Kawaguchi, Koji and Ogura, Taemi and Horikoshi, Yasuo and Takita, Junko and Watanabe, Kenichiro},
  title = {Pediatric T‐Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {8},
  doi = {10.1002/1545-5017.70412}
}
Kostenlos starten →